Moleculin Biotech
MBRX
MBRX
9 hedge funds and large institutions have $254K invested in Moleculin Biotech in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66K | |
| 2 | +$9K | |
| 3 | +$8K | |
| 4 |
WA
WFG Advisors
Dallas,
Texas
|
+$2K |
Top Sellers
| 1 | -$124K | |
| 2 | -$9K | |
| 3 | -$2.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.5K |